These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 33128625)

  • 61. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
    Hanifah S; Nugroho B; Chabib L
    Anaesthesiol Intensive Ther; 2020; 52(1):23-27. PubMed ID: 32024349
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.
    Riera P; Garrido-Alejos G; Cardenete J; Moliner E; Zapico-Muñiz E; Cardona D; Garin N
    Nutr Clin Pract; 2018 Oct; 33(5):694-700. PubMed ID: 29464781
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.
    Aghili A; Thomovsky EJ; Johnson PA; Brooks AC; Pierce TJ; Gochenauer AE
    Am J Vet Res; 2021 May; 82(5):358-366. PubMed ID: 33904804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
    Kenneally AM; Agbana P; Gardner B; Bae Y; Mitchell T; Beckman EJ
    Am J Health Syst Pharm; 2023 Jan; 80(3):164-170. PubMed ID: 36282720
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physico-chemical stability of Plasma-Lyte 148® and Plasma-Lyte 148® + 5% Glucose with eight common intravenous medications.
    Dawson R; Wignell A; Cooling P; Barrett D; Vyas H; Davies P
    Paediatr Anaesth; 2019 Feb; 29(2):186-192. PubMed ID: 30472805
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
    Holt RJ; Siegert SW; Krishna A
    J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.
    Vermeire A; Remon JP
    Int J Pharm; 1999 Jan; 177(1):53-67. PubMed ID: 10205603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug incompatibilities in the adult intensive care unit of a university hospital.
    Marsilio NR; Silva Dd; Bueno D
    Rev Bras Ter Intensiva; 2016 Jun; 28(2):147-53. PubMed ID: 27410410
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Compatibility of amifostine with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Review of binary, ternary and quaternary mixtures for induction and maintenance of opioid free anesthesia.
    Tauste-Hernández B; Cortiñas-Sáenz M; Fernández-Ginés FD; Expósito-López JM
    Farm Hosp; 2021 Apr; 45(3):135-141. PubMed ID: 33941057
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    Am J Health Syst Pharm; 1997 Jun; 54(11):1295-300. PubMed ID: 9179351
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration.
    Mody V; Shah S; Patel J; Thomas MC
    Int J Pharm Compd; 2016; 20(3):236-238. PubMed ID: 28333664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
    Ng E; Taddio A; Ohlsson A
    Cochrane Database Syst Rev; 2003; (1):CD002052. PubMed ID: 12535424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
    Lee TM; Villareal CL; Meyer LM
    Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262
    [No Abstract]   [Full Text] [Related]  

  • 80. Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit.
    Manrique-Rodríguez S; Sánchez-Galindo A; Mora-García T; Fernandez-Llamazares CM; Echarri-Martínez L; López-Herce J; Rodríguez-Gómez M; Bellón-Cano JM; Sanjuro-Sáez M
    J Infus Nurs; 2012; 35(2):109-14. PubMed ID: 22382795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.